Olivopontocerebellar Atrophy

Olivopontocerebellar atrophy (OPCA) refers to neurodegeneration of the inferior olivary nucleus, pons, and the cerebellum, and is characterized by cerebellar ataxia and other neurological problems. Here is the latest research.

July 19, 2020

Non-motor symptoms of Parkinson's disease from pathophysiology to early diagnosis

La Revue de médecine interne
M AubignatP Krystkowiak
September 14, 2020

Effects of cerebellar transcranial magnetic stimulation on ataxias: A randomized trial

Parkinsonism & Related Disorders
Carina FrançaRubens G Cury
August 11, 2020
Open Access

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia

Tremor and Other Hyperkinetic Movements
Shin-Ichi UenoNobutaka Hattori
July 19, 2020
Open Access

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models

Journal of Neuroinflammation
Michiyo IbaEliezer Masliah
August 28, 2020

Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease

Brain : a Journal of Neurology
Yiwei QianQin Xiao
July 24, 2020

Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Giuseppe CosentinoEnrico Alfonsi
August 6, 2020
Open Access

Bilateral middle cerebellar peduncle lesions: Neuroimaging features and differential diagnoses

Brain and Behavior
Jiwei JiangXiuli Shang
August 6, 2020
Open Access

The Characteristics of Tremor Motion Help Identify Parkinson's Disease and Multiple System Atrophy

Frontiers in Neurology
Dongning SuTao Feng
September 6, 2020

Reduction of Lewy Body Pathology by Oral Cinnamon

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Sumita RahaKalipada Pahan
August 29, 2020
Review
Open Access

Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays

Biomolecules
Matteo Manca, Allison Kraus
September 15, 2020

Respiratory and sleep-related complications of multiple system atrophy

Current Opinion in Pulmonary Medicine
Frank Ralls, Lisa Cutchen
July 28, 2020

The footprint of orthostatic hypotension in parkinsonian syndromes

Parkinsonism & Related Disorders
Cecilia RaccagniAlessandra Fanciulli
August 18, 2020

Expanding spectrum of prion diseases

Emerging Topics in Life Sciences
Jacob I AyersStanley B Prusiner
August 14, 2020
Case Report

Acute postoperative bilateral vocal fold paralysis after posterior spinal correction for dropped head syndrome: A case report

World Neurosurgery
Hjorleifur Skorri ThormodssonFreyr Gauti Sigmundsson
August 21, 2020
Review
Open Access

The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Jeffrey Cummings
August 6, 2020
Open Access

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017

Journal of Clinical Medicine
Maria Angela Samis ZellaLars Tönges
July 20, 2020
Review
Open Access

Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy

Stem Cell Research
Jin Young Shin, Phil Hyu Lee
September 2, 2020
Open Access

A clinical report of the massive CAG repeat expansion in spinocerebellar ataxia type 2: Severe onset in a Mexican child and review previous cases

Genetics and Molecular Biology
José Sergio Alberto Ramirez-GarciaDiana García-Cruz

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/olivopontocerebellar-atrophy/80b59296-4932-4d18-b4f2-b547423b36d8